Type 2 · Organization ✓ Active NPI ✓ Valid NPI checksum

Bioluminux Clinical Research New Jersey

Research Clinic/Center in Trenton, NJ · enumerated 2024 · authorized official Matthew Adasofunjo, Managing Director.

Data current as of Jul 13, 2026 · sourced from CMS NPPES

National Provider Identifier

1275354334

Verified

See something wrong? Report a correction

Registry record

Entity type Organization (Type 2)

Legal business name Bioluminux Clinical Research New Jersey

Practice address 2131 Route 33 Ste B, Trenton, NJ, 08690

Phone (708) 435-1404

Enumeration date Oct 22, 2024

Last updated in NPPES Oct 22, 2024

Taxonomy & classification

261QR1100X Research Clinic/Center Ambulatory Health Care Facilities Primary

Authorized official

Name Matthew Adasofunjo

Title Managing Director

Phone (708) 435-1404

What is an NPI number?

A National Provider Identifier (NPI) is a unique 10-digit number that CMS assigns to every U.S. healthcare provider and organization under HIPAA. Type 1 NPIs identify individual providers; Type 2 NPIs identify organizations. The NPI appears on insurance claims, prescriptions, and credentialing paperwork, and never changes, even if the provider moves or changes specialty.

Read the full guide → Validate an NPI →

Frequently asked questions

What is a Type 2 NPI?

A Type 2 NPI identifies an organization (group practice, hospital, pharmacy, lab), while Type 1 NPIs identify individual providers. Organizations bill under their Type 2 NPI.

What type of organization is Bioluminux Clinical Research New Jersey?

Bioluminux Clinical Research New Jersey is registered in NPPES as a Research Clinic/Center (its primary provider taxonomy).

Source: CMS NPPES (public data). Snapshot 2026-07-13. Provider record last updated 2024-10-22.